OSTEOGENIC SARCOMA - IMMUNOLOGICAL PARAMETERS BEFORE AND DURING IMMUNOTHERAPY WITH TUMOR-SPECIFIC TRANSFER-FACTOR

被引:97
作者
LEVIN, AS
BYERS, VS
FUDENBERG, HH
WYBRAN, J
HACKETT, AJ
JOHNSTON, JO
SPITLER, LE
机构
[1] UNIV CALIF, SCH MED, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF, BERKELEY, CA 94720 USA
[3] WESTERN LABS, OAKLAND, CA 94609 USA
[4] KAISER FDN HOSP, OAKLAND, CA 94611 USA
关键词
D O I
10.1172/JCI107955
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:487 / 499
页数:13
相关论文
共 29 条
[1]   TUMOR-SPECIFIC CELL-MEDIATED-IMMUNITY IN HOUSEHOLD CONTACTS OF CANCER-PATIENTS [J].
BYERS, VS ;
LEVIN, AS ;
HACKETT, AJ ;
FUDENBERG, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (03) :500-513
[2]   FUTURE OF TUMOR IMMUNOLOGY [J].
CINADER, B .
MEDICAL CLINICS OF NORTH AMERICA, 1972, 56 (03) :801-+
[3]  
Fisher B, 1971, Adv Surg, V5, P189
[4]  
JAFFE N, 1972, CANCER-AM CANCER SOC, V30, P1627, DOI 10.1002/1097-0142(197212)30:6<1627::AID-CNCR2820300631>3.0.CO
[5]  
2-H
[6]  
JOHNSTON JO, 1972, PATHOLOGY BONE TUMOR, P1
[7]  
Lawrence H S, 1969, Adv Immunol, V11, P195, DOI 10.1016/S0065-2776(08)60480-0
[9]  
LAWRENCE HS, 1969, MEDIATORS CELLULAR I
[10]  
LEVIN A S, 1972, Clinical Research, V20, P568